| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/29/1998 | CA2260990A1 Pyrazolopyridine compound and pharmaceutical use thereof |
| 01/29/1998 | CA2260983A1 Certain amido- and amino-substituted benzylamine derivatives; a new class of neuropeptite y1 specific ligands |
| 01/29/1998 | CA2260982A1 Certain substituted benzylamine derivatives; a new class of neuropeptide-y1 specific ligands |
| 01/29/1998 | CA2260859A1 Thiol sulfone metalloprotease inhibitors |
| 01/29/1998 | CA2259552A1 Method of treating sinusitis with uridine triphosphates and related compounds |
| 01/29/1998 | CA2256736A1 New triazolopurines, method of preparing them and their use as drugs |
| 01/28/1998 | EP0821068A2 Novel sphingolipids and a process thereto |
| 01/28/1998 | EP0821007A2 Aprotinin variants with improved properties |
| 01/28/1998 | EP0821004A1 Novel peptides and remedy for bone diseases containing the same as active ingredient |
| 01/28/1998 | EP0820991A2 Cycloalkyl derivatives as bone resorption inhibitors and vitronectin receptor antagonists |
| 01/28/1998 | EP0820990A2 Novel benzimidazole, benzoxazole, and benzothiazole derivatives useful as interleukin 1beta inhibitors |
| 01/28/1998 | EP0820988A2 Imino derivatives as bone resorption inhibitors and vitronectin receptor antagonists |
| 01/28/1998 | EP0820507A1 Ndf peptides |
| 01/28/1998 | EP0820461A1 Chemical compounds |
| 01/28/1998 | EP0820455A1 5H, 10H-IMIDAZO [1,2-a]INDENO [1,2-e]PYRAZIN-4-ONE DERIVATIVES, PREPARATION THEREOF, AND DRUGS CONTAINING SAID DERIVATIVES |
| 01/28/1998 | EP0820453A1 Thrombin inhibitors |
| 01/28/1998 | EP0820452A1 Carbonyl-piperazinyl and piperidinil compounds which inhibit farnesyl protein transferase |
| 01/28/1998 | EP0820451A1 Novel heterocyclic compounds |
| 01/28/1998 | EP0820450A1 Novel heterocyclic compounds |
| 01/28/1998 | EP0820445A1 Inhibitors of farnesyl-protein transferase |
| 01/28/1998 | EP0820444A1 1-phenylpyrazole-3-carboxamides acting on neurotensin receptors |
| 01/28/1998 | EP0820442A1 Novel heterocyclic compounds |
| 01/28/1998 | EP0820441A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS |
| 01/28/1998 | EP0820434A1 Phenoxyethylamine derivatives having high affinity for the 5-ht 1a receptor, preparation thereof, use thereof as drugs, and pharmaceutical compositions containing said derivatives |
| 01/28/1998 | EP0820433A1 O-malonyltyrosyl compounds, o-malonyltyrosyl compound-containing peptides, and uses thereof |
| 01/28/1998 | EP0820313A2 Radiolabeled peptides for diagnosis and therapy |
| 01/28/1998 | EP0820291A1 A pharmaceutical composition containing n-phosphonoglycine derivatives for inhibiting the growth of viruses and cancers |
| 01/28/1998 | EP0820290A1 Use of vitamin d 2 or vitamin d 4-derivatives for the manufacture of a medicament for the treatment of secondary hyperparathyroidism |
| 01/28/1998 | EP0820283A1 Lactacystin analogs |
| 01/28/1998 | EP0820275A1 Cosmetic melanins |
| 01/28/1998 | EP0715613B1 New diphenylhexene |
| 01/28/1998 | CN1171816A CDNA encoding BMP type II receptor |
| 01/28/1998 | CN1171789A 6 -£triazolyl £3 -(trifluoromethyl) phenyl|methyl| -2 -quinolinones and quinolinethiones |
| 01/28/1998 | CN1171780A Hydroxamic acid-containing inhibitors of matrix metalloproteases |
| 01/28/1998 | CN1171741A Freeze-dried ondanstetron compositions |
| 01/28/1998 | CN1171740A Oral compositions containing ondansetron |
| 01/28/1998 | CN1171736A Matrix type patch preparations |
| 01/28/1998 | CN1171401A New 3-(piperid-4-yl)-1, 2 -benzisoxazole and 3-(piperazin-4-yl) -1, 2-benzisoxazole compounds, processes for their preparation and pharmaceutical compositions containing them |
| 01/28/1998 | CN1171396A 4-hydroxy-piperdine derivatives |
| 01/28/1998 | CN1171238A Method for enhancing anticarcinogenic effect |
| 01/28/1998 | CN1037201C 多元溶剂清洗系统 Multiple solvent cleaning system |
| 01/28/1998 | CN1037176C Benzenealkanoic acids for cardiovascular diseases |
| 01/27/1998 | US5712380 Angiogenesis inhibitor |
| 01/27/1998 | US5712300 Hydroxamic acid derivatives useful for the treatment of diseases related to connective tissue degradation |
| 01/27/1998 | US5712298 Bronchodilator agents, treatment of asthma, antiinflammatory, treatment of skin disorders |
| 01/27/1998 | US5712296 Substituted pyridines and 2-oxo-1,2-dihydropyridines |
| 01/27/1998 | US5712292 N-substituted azaheterocyclic carboxylic acids and esters thereof |
| 01/27/1998 | US5712291 Methods and compositions for inhibition of angiogenesis |
| 01/27/1998 | US5712280 Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| 01/27/1998 | US5712279 Inhibitors of microsomal triglyceride transfer protein and method |
| 01/27/1998 | US5712273 Amino acid derivatives, processes for the manufacture thereof and pharmaceutical compositions (II) containing these compounds |
| 01/27/1998 | US5712253 Macrocyclic 13-membered ring derivatives of erythromycins A and B |
| 01/27/1998 | US5712249 Use of insulin-like growth factors I and II for inhibition of inflammatory response |
| 01/27/1998 | US5712111 DNA encoding bradykinin B1 receptor |
| 01/27/1998 | US5711969 Large area submucosal tissue graft constructs |
| 01/27/1998 | US5711958 Chain extended lactone-alkylene oxide block polymers |
| 01/27/1998 | US5711957 Use of a porous calcium carbonate based material as support of a growth factor in the preparation of a bioabsorbable implant |
| 01/27/1998 | US5711944 Interferon polymer conjugates |
| 01/27/1998 | CA2037009C 15-dehydroxy-16-oxoprostaglandins |
| 01/27/1998 | CA1339645C Pyridinium derivatives, their production and use |
| 01/25/1998 | CA2207071A1 Aprotinin variants having improved properties |
| 01/24/1998 | CA2211148A1 Novel imino derivatives as inhibitors of bone resorption and vitronectin receptor antagonists |
| 01/22/1998 | WO1998002578A1 Silanol enzyme inhibitors |
| 01/22/1998 | WO1998002541A1 Gamma-heregulin |
| 01/22/1998 | WO1998002452A2 Compounds and methods for modulating cell adhesion |
| 01/22/1998 | WO1998002440A1 3-ureido-pyridofurans and -pyridothiophenes for the treatment of inflammatory processes |
| 01/22/1998 | WO1998002438A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 01/22/1998 | WO1998002437A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 01/22/1998 | WO1998002436A1 Thiadioxobenzodiazepine inhibitors of farnesyl protein transferase |
| 01/22/1998 | WO1998002183A1 Medicinal compositions |
| 01/22/1998 | WO1998002171A1 Methods and compositions for reducing or eliminating post-surgical adhesion formation |
| 01/22/1998 | WO1998002166A1 Adenosine deaminase inhibitors |
| 01/22/1998 | WO1998002161A1 Deoxynojirimycin derivatives and their uses as glucosylceramidase inhibitors |
| 01/22/1998 | WO1998002160A1 Method for treating and preventing neurodegenerative disorders by administering a thiazolidinone |
| 01/22/1998 | CA2261591A1 Adenosine deaminase inhibitors |
| 01/22/1998 | CA2260216A1 Thiadioxobenzodiazepine inhibitors of farnesyl protein transferase |
| 01/22/1998 | CA2260061A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 01/22/1998 | CA2260058A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 01/22/1998 | CA2259966A1 Compounds and methods for modulating cell adhesion |
| 01/22/1998 | CA2258685A1 Silanol enzyme inhibitors |
| 01/22/1998 | CA2255073A1 Method for treating and preventing neurodegenerative disorders by administering a thiazolidinone |
| 01/21/1998 | EP0819681A2 N-(4-Aryl-thiazol-2-yl)-sulfonamides and their use |
| 01/21/1998 | EP0819433A2 Compositions for increasing the efficacy of cancer drugs with tea catechin and/or theaflavin |
| 01/21/1998 | EP0819168A1 Human tumor necrosis factor receptor |
| 01/21/1998 | EP0819137A1 Peptides with growth promotion properties |
| 01/21/1998 | EP0819136A1 Mdp derivatives and conjugates having haematopoietic function stimulating activity, and compositions containing same |
| 01/21/1998 | EP0819135A1 Sugar-modified cytostatics |
| 01/21/1998 | EP0819129A1 Pyrazole derivatives and processes for the preparation thereof |
| 01/21/1998 | EP0819125A1 Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin |
| 01/21/1998 | EP0819121A1 Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 01/21/1998 | EP0819120A1 Tricyclic compounds useful for inhibition of farnesyl protein transferase |
| 01/21/1998 | EP0819008A1 Method of using lectins for prevention and treatment of skin diseases and disorders |
| 01/21/1998 | EP0819007A1 Urinary bladder submucosa derived tissue graft |
| 01/21/1998 | EP0819003A1 A method for the treatment of macular degeneration |
| 01/21/1998 | EP0701443B1 Terfenadine metabolites and their optically pure isomers for treating allergic disorders |
| 01/21/1998 | EP0660821B1 Non-metabolizable clomiphene analogs for treatment of tamoxifen-resistant tumors |
| 01/21/1998 | EP0625977B1 Piperazine derivatives as 5-ht1a antagonists |
| 01/21/1998 | EP0527917B1 Use of adenosine and adenosine derivatives for anesthesia |
| 01/21/1998 | CN1171115A 14 alpha, 17 alpha-C2-bridged 19-nor-progesterone derivatives |
| 01/21/1998 | CN1171113A Mutants of Rb and p53 genes and uses thereof |